Resources

MBC Resources aren’t limited to Clinical Trials, Research and Reports! We encourage the MBC Community and Caregivers to provide links to active resources as well as suggest additional resources – provided or needed. Please email your ideas to info@mbccanada.org (subject line “Resources”).

Novartis – Kisquali press release

https://www.novartis.com/news/media-releases/novartis-kisqali-delivers-consistently-superior-overall-survival-monaleesa-3-trial-demonstrates-more-life-postmenopausal-hrher2-advanced-breast-cancer-patients

Secondary Analysis of the TAILORx Randomized Clinical Trial

https://jamanetwork.com/journals/jamaoncology/fullarticle/2752332?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=093019#.XZIRft-wQRo.twitter

Regulatory T Cells Control the Switch From in situ to Invasive Breast Cancer

https://www.frontiersin.org/articles/10.3389/fimmu.2019.01942/full

Strategies for Overcoming CDK4/6 Inhibition Emerge in ER+ Breast Cancer

https://www.targetedonc.com/publications/targeted-therapy-news/2019/august-2019/strategies-for-overcoming-cdk46-inhibition-emerge-in-er-breast-cancer

The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2 #ESMO19 on 9/29

https://jamanetwork.com/journals/jamaoncology/fullarticle/2752266?utm_source=twitter&utm_campaign=content-shareicons&utm_content=article_engagement&utm_medium=social&utm_term=092919#.XZDO5Vqh8Tg.twitter

Close Menu